Kun Liu
5 Papers
2 Citations
Kun Liu is an academic researcher. The author has contributed to research in topics: Medicine & Survival analysis. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
•Journal Article
Efficacy analysis of two drugs consisting platinum combined with first-line chemotherapeutics regimens on 117 elderly patients with advanced non-small cell lung carcinoma
TL;DR: Clinicopathological factors are closely related to one-, three- and five-year survival rates of advanced NSCLC in elderly patients who received treatment of first-line chemotherapeutics plus platinum.
2
Prognostic significance of CDK6 amplification in esophageal squamous cell carcinoma.
Kun Liu,Hua-Rong Lu,Dongxian Jiang,Yingying Guan,Huijuan Xu,Qi Sun,Qiuli Jiang,Jin-tao Zheng,Huan-Wei Chen,Fuhan Zhang,Ruichen Luo,Ying Huang,Jian-feng Xu,Yingyong Hou +13 more
TL;DR: In this paper , the frequency and prognostic value of CDK6 amplification to improve the risk stratification in patients with esophageal squamous cell carcinoma (ESCC) was investigated.
1
Relationship between body mass index and depressive symptoms: the "fat and jolly" hypothesis for the middle-aged and elderly in China
TL;DR: The data are consistent with the “fat and jolly” hypothesis being valid in both middle-aged and elderly men and women.
Association of CDX2 and mucin expression with chemotherapeutic benefits in patients with stage II/III gastric cancer
Xianchun Gao,Weili Han,Ling Chen,Hong-wang Li,Fenli Zhou,Bin Bai,Junya Yan,Yong-long Guo,Kun Liu,Wenjiao Li,Renlong Li,Qi Yuan,Jie Zhang,Yuanyuan Lu,Xiaodi Zhao,Gang Ji,Mengbin Li,Qingchuan Zhao,Kaichun Wu,Zeng-Huai Li,Yongzhan Nie +20 more
TL;DR: This study aimed to assess the ability of CDX2 and mucin markers to predict prognosis and fluorouracil‐based adjuvant chemotherapy benefits in patients with stage II/III gastric cancer.
Impact of HER2 on prognosis and benefit from adjuvant chemotherapy in stage II/III gastric cancer patients: a multicenter observational study.
Xianchun Gao,Lulu Zhao,Nan-Nan Zhang,Weili Han,Kun Liu,Ling Chen,Yan-Yun Pan,Renlong Li,Wenjiao Li,Haohao Zhang,Hongwei Li,Shibo Wang,Xiaoliang Gao,Penghui Niu,Wanqing Wang,Gang Ji,Qingchuan Zhao,Yuanyuan Lu,Zeng-Huai Li,Lei Shang,Han Liang,Kaichun Wu,Jingyu Deng,Chen Yingtai,Yongzhan Nie +24 more
TL;DR: In this article , the impact of HER2 on survival and benefit from fluorouracil-based adjuvant chemotherapy remains unclear in patients with breast and gastric cancer (GC).